COMPANY INFO
Innovaccer Inc. is a digital healthcare company founded in 2012 by Abhinav Shashank, Kanav Hasija, and Sandeep Gupta. The company has around 1,500 employees and is headquartered in San Francisco, California, with a website at www.innovaccer.com. Innovaccer provides an AI-powered healthcare intelligence cloud platform that integrates fragmented healthcare data into actionable insights, enhancing patient care and operational efficiency. It supports healthcare organizations in value-based care initiatives by enabling connected, data-driven decision-making across the continuum of care. (innovaccer.com/about, crunchbase.com/organization/innovaccer, en.wikipedia.org/wiki/Innovaccer)
This page is built with Exa, a web search API for AI agents. It is updated every 24 hours.
Innovaccer Inc. is a leading digital healthcare company founded in 2014 by Abhinav Shashank, Kanav Hasija, and Sandeep Gupta. Headquartered in San Francisco, California, Innovaccer employs approximately 1,500 people and specializes in healthcare data analytics and artificial intelligence. The company’s cloud-based healthcare intelligence platform integrates fragmented data to deliver actionable insights, driving better patient care and operational efficiency. Innovaccer empowers healthcare organizations to succeed in value-based care models by facilitating connected, data-driven decision-making across the continuum of care.
Innovaccer Inc. funding history reflects a strongly growth-oriented and strategic approach. To date, the company has raised approximately $675 million through 9 funding rounds from a robust group of venture capital and institutional investors. Key milestones include scaling their AI-powered healthcare cloud, expanding into new markets, and enhancing product capabilities. Funding has supported both product development and expansion initiatives, and the company’s valuation has climbed significantly, reaching a post-money valuation of $3.45 billion after its most recent Series F round in January 2025. This progressive fundraising strategy underscores Innovaccer Inc.'s position as a major innovator in healthcare data analytics.
This Series F round was structured to support the scaling of Innovaccer Inc.’s healthcare intelligence cloud platform. The round included substantial primary and secondary investments, with 35% allocated for liquidity to early seed and Series A investors. This infusion is set to fuel Innovaccer’s next phase of growth and solidify its leadership in AI-driven healthcare.
The Series E round focused on further market expansion and scaling operations. This was Innovaccer’s largest round at the time, boosting its post-money valuation to $3.2 billion and accelerating ambitious growth plans.
Series D funding was primarily aimed at propelling company growth, scaling staffing and operations across existing and new markets, and supporting product innovation. The valuation at this stage reached $1.3 billion.
Funds from the Series C round were used for product development as well as expansion into new markets, supporting Innovaccer Inc.’s mission to deliver data-driven healthcare transformation.
This Series B round, led by prominent venture capital firms, was geared toward business scaling and expanding market reach.
An additional Series B injection helped Innovaccer continue scaling its operations and product offerings.
This early growth round funded initial product development and organizational scaling.
Seed funding supported Innovaccer’s initial launch and product development, providing crucial early-stage capital.
An initial undisclosed seed round primarily supported the company’s launch activities.
B Capital Group is a leading global venture capital firm investing across multiple rounds and playing a critical role in Innovaccer Inc. funding. Their ongoing partnership has been instrumental in supporting Innovaccer’s strategic vision and growth.
Banner Health, through its venture and innovation divisions, has contributed both capital and healthcare industry expertise, supporting Innovaccer’s efforts to integrate healthcare data systems.
Danaher Ventures LLC is the investment division of Danaher Corporation, providing strategic funding and industry alignment for Innovaccer’s advanced healthcare solutions.
Generation Investment Management, co-founded by Al Gore, focuses on sustainable investing and has backed Innovaccer Inc. as part of their commitment to data-driven health innovation.
Kaiser Permanente, one of the largest healthcare providers in the United States, has invested to further integrated care solutions and align with Innovaccer's mission of value-based patient care.
M12, Microsoft’s venture capital arm, has been a significant investor in multiple rounds, bringing not only funding but strong technological partnership and cloud expertise to Innovaccer funding rounds.
Schonfeld is a global investment management firm providing capital for Innovaccer’s expansion and scale-up strategies during key late-stage funding rounds.
Whale Rock Capital Management, a technology-focused investment firm, supported Innovaccer’s Series E round, strengthening its late-stage financial position.
Mubadala Capital Ventures, based in Abu Dhabi, has been part of several later-stage rounds, broadening Innovaccer’s global reach and connections.
OMERS, one of Canada’s largest pension funds, backed Innovaccer during several strategic rounds, aligning with their commitment to long-term healthcare disruption.
Dragoneer, known for investing in leading growth companies, was a key player in multiple Innovaccer venture capital rounds, facilitating rapid scaling.
Steadview Capital is a global long-term investor providing both capital and operational expertise across several rounds of Innovaccer funding.
Tiger Global Management, one of the most prolific venture capital investors, backed Innovaccer during pivotal growth rounds, enabling swift expansion.
Avidity Partners contributed to Innovaccer’s Series E round, focusing on advancing healthcare technology as part of its investment thesis.
WestBridge Capital has been a prominent backer since the early stages, including Series A and B rounds, aiding Innovaccer Inc.’s initial scaling and product launch.
Lightspeed India participated in early funding rounds, supporting Innovaccer’s venture and growth within India and internationally.
Pravega Ventures was involved in early-stage financing, nurturing Innovaccer’s foundational growth and initial product market fit.
Peak XV Partners (formerly Sequoia Capital India & Southeast Asia) provided additional global venture capital network support.
Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching Innovaccer Inc. funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.
With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.
This page is built with Exa, a web search API for AI agents. It is updated every 24 hours.
Exa searches the web, extracts relevant source content, and returns structured outputs with citations.
const run = await exa.agent.runs.create({
query: "Research Innovaccer's funding rounds, key investors, total raised, and latest funding date. Return structured JSON with field-level citations.",
effort: "low",
outputSchema: {
// company, fundingRounds, keyInvestors, totalRaised
/* ... */
}
});
const result = await exa.agent.runs.pollUntilFinished(run.id);{
"status": "completed",
"output": {
"structured": {
"company": "Innovaccer",
"fundingRounds": [
"..."
],
"keyInvestors": [
"..."
],
"totalRaised": "$675 million over 9 funding rounds. Latest funding was a Series F round on January 9, 2025. Key investors include B Capital, Banner MD Anderson Cancer Center, Generation Investment Management, Kaiser Permanente, M12, Danaher, Schonfeld, Whale Rock Capital Management, Mubadala, OMERS, Dragoneer Investment Group, Steadview, Tiger Global Management, Avidity Partners, WestBridge Capital, and Lightspeed India. Detailed breakdown:\n\n- Jan 09, 2025: Series F, amount undisclosed, investors included B Capital, Banner MD Anderson Cancer Center, Generation Investment Management, Kaiser Permanente, M12, Danaher. Purpose: Scaling healthcare intelligence cloud.\n- Dec 14, 2021: Series E, $150M, led by Schonfeld, other investors Whale Rock Capital, Mubadala, B Capital, OMERS, M12, Dragoneer, Steadview, Tiger Global, Avidity Partners. Purpose: Market expansion and growth.\n- Feb 19, 2021: Series D, $105M, led by Tiger Global Management, Steadview, Dragoneer, Mubadala, M12, OMERS, B Capital. Purpose: Product development and scaling.\n- Oct 08, 2019: Series C, $70M, investors included Steadview, Tiger Global, Dragoneer, Mubadala, WestBridge Capital, M12. Purpose: Growth and expansion.\n- May 09, 2018: Series B, $25M, investors WestBridge Capital, M12, Lightspeed India. Purpose: Market expansion.\n- Jan 16, 2019: Series B, $10M, investors M12, WestBridge Capital, Lightspeed India. Purpose: Market expansion.\n- Jul 13, 2016: Series A, $15.6M, led by WestBridge Capital, Raymie Stata, Pravega Ventures, Herb Madan. Purpose: Product development.\n- May 13, 2015: Seed, $3M, investors 500 Global, Start Smart Labs, Rajan Anandan, Teruhide Sato, Aneesh Reddy Boddu, Venkatesh Valluri, Phanindra Sama, Ssaa, Six Sigma Academy. Purpose: Initial launch.\n- Jan 27, 2015: Seed, amount undisclosed, investor 500 Global. Purpose: Initial launch."
},
"grounding": [
{
"field": "fundingRounds[0].amount",
"citations": [
{
"url": "..."
}
]
}
]
}
}